Odimma
Illkirch-graffenstaden
About Odimma
Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Seed (Apr 2023)
- Website: odimma-therapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Precision Medicine, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/odimma-6750 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.